Curious to see the emissions of the organizations you buy from or invest in?
Book a demo for a pilot project
Doc Generici, officially known as Doc Generici S.p.A., is a prominent player in the pharmaceutical industry, headquartered in Italy. Established in 2000, the company has rapidly expanded its operations across major regions in Europe, focusing on the development and distribution of generic medicines.
Specialising in high-quality generics, Doc Generici offers a diverse portfolio of products that stand out for their efficacy and affordability. The company is committed to innovation and sustainability, ensuring that its offerings meet rigorous regulatory standards while addressing the needs of healthcare providers and patients alike.
With a strong market position, Doc Generici has achieved notable milestones, including significant partnerships and a growing presence in the European market, solidifying its reputation as a trusted name in the pharmaceutical sector.
18
DitchCarbon score
-24 vs industry average
Doc Generici’s score of 18 is lower than 33% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Doc Generici?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Very Low
Pharmaceutical Preparation Manufacturing is among the least carbon-intensive industries
Industry performance
0.243
02025
The Pharmaceutical Preparation Manufacturing industry has increased its overall emissions by 132% since 0
Reported emissions
No reported emissions data is available for Doc Generici yet.
Doc Generici's reported carbon emissions
Doc Generici, headquartered in Italy, currently does not have available carbon emissions data for the most recent year. As a result, specific figures regarding their total emissions, including Scope 1, Scope 2, and Scope 3, are not provided.
The company is a current subsidiary of Doc Generici SRL, and any potential emissions data or climate commitments may be cascaded from this parent organization. However, no specific reduction targets or climate initiatives have been documented for Doc Generici at this time.
In the absence of concrete emissions data, it is important to note that the pharmaceutical industry is increasingly focusing on sustainability and reducing carbon footprints. Companies are encouraged to set science-based targets and engage in initiatives aimed at mitigating climate change impacts.
As Doc Generici continues to develop its sustainability strategy, stakeholders can anticipate future commitments and data disclosures that align with industry standards and climate action goals.
Assessing Doc Generici as a supplier or portfolio company?
- See verified emissions data for over 2 million organizations
- View emissions forecasts for Doc Generici and the organizations you buy from or invest in
- Get PCAF data quality (DQ) scores, including for private organizations
Doc Generici’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for Doc Generici yet.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Climate initiatives
Science Based Targets Initiative
See details
Not active
Carbon Disclosure Project
See details
Not active
The Climate Pledge
See details
Not active
UN Global Compact Climate Champions initiative
See details
Not active
RE 100
See details
Not active
Climate Action 100
See details
Not active
Emissions comparison with industry peers
View similar organisationsCompanyCountryIndustryLast updatedScoreDetails
Doc Generici1 year ago
18
Need this data for financed emissions?
PCAF scored Scope 1, 2 and 3 for 2M+ organizations, including private ones.
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more